We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ICCC market cap is 46.52M. The company's latest EPS is USD -0.6480 and P/E is -8.06.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 5.4M | 5.1M | 7.26M | 5.47M | 6.01M |
| Operating Income | -1.18M | -1M | -300k | -1.39M | -574k |
| Net Income | -940k | -1.14M | -438k | -1.53M | -702k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 13.72M | 15.34M | 19.24M | 18.57M | 17.47M |
| Operating Income | -954k | -1.38M | 257k | -2.3M | -5.75M |
| Net Income | -1.3M | -1.02M | -78k | -2.49M | -5.78M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 44.55M | 43.81M | 43.05M | 41.86M | 44.45M |
| Total Liabilities | 18.53M | 18.82M | 18.42M | 18.4M | 18.04M |
| Total Equity | 26.01M | 24.99M | 24.64M | 23.46M | 26.41M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 38.69M | 40.35M | 44.47M | 44.86M | 43.81M |
| Total Liabilities | 9.7M | 12.08M | 11.89M | 14.48M | 18.82M |
| Total Equity | 28.99M | 28.27M | 32.58M | 30.38M | 24.99M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -3.95M | -4.67M | 418k | 1M | 361k |
| Investing | -1.92M | -1.89M | -70k | -177k | -265k |
| Financing | 2.07M | 1.75M | -367k | -478k | 2.73M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 234k | 1.32M | 954k | -1.54M | -4.67M |
| Investing | -3.4M | -2.57M | -1.6M | -3.96M | -1.89M |
| Financing | 6.94M | 1.91M | 3.88M | 1.12M | 1.75M |
| Market Cap | 46.52M |
| Price to Earnings Ratio | -8.06 |
| Price to Sales Ratio | 2.66 |
| Price to Cash Ratio | 47.5 |
| Price to Book Ratio | 1.86 |
| Dividend Yield | - |
| Shares Outstanding | 8.91M |
| Average Volume (1 week) | 13.8k |
| Average Volume (1 Month) | 15.14k |
| 52 Week Change | 5.88% |
| 52 Week High | 5.82 |
| 52 Week Low | 3.34 |
| Spread (Intraday) | 0.98 (17.82%) |
| Company Name | ImmuCell Corporation |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.immucell.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
